1. Home >
  2. Companies >
  3. Life Science >
  4. United States >
  5. Massachusetts >
  6. 2seventy bio

2seventy bio - Ownership and Business Overview

Life ScienceCompany

2seventy bio Ownership

Who owns 2seventy bio?

2seventy bio is owned by Bristol-Myers Squibb. It was acquired on March 10, 2025.

2seventy bio Business Overview

Where is 2seventy bio headquartered?

2seventy bio is headquartered in Cambridge, Massachusetts.

What is 2seventy bio’s revenue?

2seventy bio disclosed revenue of 100M USD for 2023 and 91M USD for 2022.

What sector is 2seventy bio in?

2seventy bio is a life science company.

When was 2seventy bio founded?

2seventy bio was founded in 2021.

Life Science M&A Summary in 2025

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2025. The largest life science acquisition in 2025 was Intra-Cellular Therapies - which was acquired by Johnson & Johnson for $14.6B.

Subscribe to Mergr to view all 108 acquisitions of life science companies in 2025, including 5 acquisitions by private equity firms, and 103 by strategics.

2seventy bio

2seventy bio, Inc.

60 Binney St.,
Cambridge, Massachusetts 02142
United States,
(617) 675-7270
www.2seventybio.com

2seventy bio is an immuno-oncology cell therapy company focused on discovering and developing new therapies that truly disrupt the cancer treatment landscape. 2seventy bio was formed in 2021 and is based in Ottawa, Ontario.


Company Summary

SECTOR

Life Science

Revenue

100   10% 2023
91   66% 2022
55   2021
(millions of USD)

Established

2021

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for 2seventy bio

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal